Table 3.
Cardiovascular screened articles included and deleted
|
|
Included |
Deleted |
Reason for deletion |
|
1. |
Li et al.13 2017 (Cochrane) (1 RCT) |
Lockhart et al.22 2012 (US) |
N/A to PICO |
|
2. |
Schmitt et al.14 2015 (France) (8 observational & 2 intervention studies) |
Martin-Cabezas et al.28 2016 (France) |
No intervention studies & only 2 cohort studies out of 20 studies |
|
3. |
Orlandi et al.15 2014 (UK) (25 cohort & 1 intervention study) |
Dai et al.29 2015 (China) |
Not relevant to PICO |
|
4. |
Teeuw et al.16 2014 (Netherlands) (25 intervention studies) |
Xian-Tao Zeng et al.30 2016 (China) |
No intervention studies included |
|
5. |
Teixeira de Freitas et al.17 2012 (Brazil) (4 RCTs & 7 non-RCT intervention trials) |
Lopez N.31 2014 (Chile) |
Critical summary of Teeuw et al. |
|
6. |
Paraskevas et al.18 2008 (Netherlands) (4 intervention studies) |
Levac et al.32 2010 (Canada) |
N/A to PICO (scoping review) |
|
7. |
Ioannidou et al.19 2006 (US) (7 cohort and 3 RCTs) |
Cheng et al.33 2018 (China) |
No intervention studies |
|
8. |
|
Leira et al.34 2017 (Spain) |
No intervention studies |
|
9. |
|
Sfyroeras et al.35 2012 (Greece) |
No intervention studies |
|
10. |
|
Kelly et al.36 2013 (US) |
N/A to PICO |
|
11. |
|
Mustapha et al.37 2007 (US) |
N/A to PICO |
|
12. |
|
Shi et al.38 2016 (China) |
No intervention studies |
|
13. |
|
Lam et al.39 2011 (UK) |
N/A to PICO |
|
14. |
|
Matthews D.40 2011 (Canada) |
Critical summary of Lam et al. |
|
15. |
|
Dietrich et al.41 2013 (UK) |
N/A to PICO |
|
16. |
|
Xu et al.42 2017 (China) |
N/A to PICO |
|
17. |
|
Leng et al.43 2015 (China) |
N/A to PICO |
|
18. |
|
Merchant A.44 2012 (US) |
Critical summary of Lockhart et al. |
|
19. |
|
Lafon et al.45 2014 (France) |
N/A to PICO |
|
20. |
|
Helfand et al.46 2009 (US) |
N/A to PICO |